20 May 2022 --- This week in nutrition news, the US Food and Drug Administration (FDA) made draft guidance available, with the goal of enhancing the amount of safety information the agency has regarding the dietary supplement market. Probiotic producer BioGaia will begin its own distribution in Canada in a move to increase B2C sales in 2023. Meanwhile, an initial American Herbal Products Association (AHPA) time study results predict a cost of roughly US$20 million for the Durbin/Braun product listing bill’s initial compliance.